Jane Street’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-390,282
| Closed | -$597K | – | 5335 |
|
|
2025
Q1 | $597K | Sell |
390,282
-155,282
| -28% | -$238K | ﹤0.01% | 3709 |
|
|
2024
Q4 | $1.35M | Buy |
545,564
+462,837
| +559% | +$1.15M | ﹤0.01% | 2584 |
|
|
2024
Q3 | $95.1K | Sell |
82,727
-252,282
| -75% | -$290K | ﹤0.01% | 5489 |
|
|
2024
Q2 | $369K | Buy |
335,009
+3,269
| +1% | +$3.6K | ﹤0.01% | 4818 |
|
|
2024
Q1 | $411K | Buy |
331,740
+72,356
| +28% | +$89.7K | ﹤0.01% | 4295 |
|
|
2023
Q4 | $272K | Buy |
259,384
+95,324
| +58% | +$100K | ﹤0.01% | 4721 |
|
|
2023
Q3 | $1.12M | Buy |
164,060
+13,025
| +9% | +$89.2K | ﹤0.01% | 2815 |
|
|
2023
Q2 | $1.57M | Sell |
151,035
-26,426
| -15% | -$274K | ﹤0.01% | 2638 |
|
|
2023
Q1 | $1.44M | Buy |
+177,461
| New | +$1.44M | ﹤0.01% | 2404 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5440 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5688 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5456 |
|
|
2022
Q1 | – | Sell |
-31,228
| Closed | -$454K | – | 5573 |
|
|
2021
Q4 | $454K | Sell |
31,228
-9,492
| -23% | -$138K | ﹤0.01% | 3581 |
|
|
2021
Q3 | $733K | Buy |
+40,720
| New | +$733K | ﹤0.01% | 3005 |
|
|
2021
Q2 | – | Sell |
-24,302
| Closed | -$612K | – | 5103 |
|
|
2021
Q1 | $612K | Buy |
24,302
+11,601
| +91% | +$292K | ﹤0.01% | 3110 |
|
|
2020
Q4 | $82K | Sell |
12,701
-16,771
| -57% | -$108K | ﹤0.01% | 3678 |
|
|
2020
Q3 | $76K | Sell |
29,472
-172,711
| -85% | -$445K | ﹤0.01% | 3495 |
|
|
2020
Q2 | $328K | Buy |
+202,183
| New | +$328K | ﹤0.01% | 2953 |
|
|
2019
Q4 | – | Sell |
-14,476
| Closed | -$16K | – | 3222 |
|
|
2019
Q3 | $16K | Sell |
14,476
-17,071
| -54% | -$18.9K | ﹤0.01% | 3330 |
|
|
2019
Q2 | $69K | Buy |
+31,547
| New | +$69K | ﹤0.01% | 3331 |
|